Literature DB >> 22328286

Selective depletion of hepatic Kupffer cells significantly alleviated hepatosteatosis and intrahepatic inflammation induced by high fat diet.

Lili Chen1, Hongying Ye, Xiaolong Zhao, Qing Miao, Yiming Li, Renming Hu.   

Abstract

BACKGROUND/AIMS: To address the impact of Kupffer cell ablation via intraperitoneal injection of gadolinium chloride (GdCl3) on hepatosteatosis, intrahepatic inflammation and other metabolic derangements induced by high-fat diet (HFD).
METHODOLOGY: C57/BCL male mice were fed with either standard normal diet or HFD. Meanwhile, mice received an intraperitoneal injection of either natural saline (5mL/kg) or 0.2% GdCl3 solution (10mg/kg) twice a week. After 8 weeks, intraperitoneal glucose tolerance test (IPGTT) was performed. F4/80 expression was quantified by immunohistochemistry, immunofluorescence and quantitative (q) RT-PCR. Adipokines in liver were detected via qRT-PCR.
RESULTS: HFD led to clear Kupffer cell infiltration and migration into areas surrounding the hepatic central vein. Both F4/80 expression and F4/80-positive cells in the liver were significantly reduced after GdCl3 administration (both p<0.01). Liver triglyceride and cholesterol deposition decreased dramatically after GdCl3 administration (p<0.01, p<0.05, respectively). TNF-a and IL-6 expression in mouse liver decreased significantly after Kupffer cell depletion (both p<0.01). Daily diet amount, weight and the area under IPGTT curve of the mice fed with HFD were clearly decreased after Kupffer cell depletion, though not statistically significant (all p>0.05).
CONCLUSIONS: Selective depletion of hepatic Kupffer cells significantly alleviated hepatosteatosis and intrahepatic inflammation induced by HFD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328286     DOI: 10.5754/hge11903

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis.

Authors:  Samar H Ibrahim; Gregory J Gores; Petra Hirsova; Michelle Kirby; Lili Miles; Anja Jaeschke; Rohit Kohli
Journal:  Liver Int       Date:  2013-11-20       Impact factor: 5.828

Review 2.  Macrophage functional diversity in NAFLD - more than inflammation.

Authors:  Emelie Barreby; Ping Chen; Myriam Aouadi
Journal:  Nat Rev Endocrinol       Date:  2022-05-09       Impact factor: 47.564

3.  Gadolinium Chloride Rescues Niemann⁻Pick Type C Liver Damage.

Authors:  Andrés D Klein; Juan Esteban Oyarzún; Cristian Cortez; Silvana Zanlungo
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

Review 4.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Detlef Schuppan; Henning Grønbæk; Konstantin Kazankov; Simon Mark Dahl Jørgensen; Karen Louise Thomsen; Holger Jon Møller; Hendrik Vilstrup; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

Review 5.  Macrophage Subsets in Obesity, Aligning the Liver and Adipose Tissue.

Authors:  Anneleen Remmerie; Liesbet Martens; Charlotte L Scott
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-29       Impact factor: 5.555

Review 6.  Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

Authors:  Patricia Rada; Águeda González-Rodríguez; Carmelo García-Monzón; Ángela M Valverde
Journal:  Cell Death Dis       Date:  2020-09-25       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.